A New Treatment for Macular Degeneration
If you are interested in learning more about this company or technology complete the form below. First*: Last*: Company / Organization*: Email*: Comments or questions: […]
If you are interested in learning more about this company or technology complete the form below. First*: Last*: Company / Organization*: Email*: Comments or questions: […]
Cardiogenesis, the clinical and market leader in transmyocardial revascularization (TMR), revealed this week that it has enrolled its first two patients for its feasibility study involving the cutting-edge PHOENIX System.
Time is critical when a patient suffers from a stroke.
Medical device company NeoVista, Inc., recently announced 12-month results from its MERITAGE study in patients with wet age-related macular degeneration, a leading cause of vision loss in older Americans.
This company is a biopharmaceutical company that has developed a targeted drug platform that specifically modulates the bioactive enzyme protein kinase C in the treatment of various conditions, including heart disease and acute chronic pain. Protein kinase C is a fundamental bioactive protein that plays a critical role in cellular signaling pathway’s, and through…
This company is a specialty biopharmaceutical company that has established a drug development platform to actualize an orally administered, low-dose version of the drug interferon, which is a well characterized immune system modulator. Interferon serves as one of the most…
This company is a specialty biopharmaceutical company that develops drugs specifically for the acute-care hospital setting. The company has developed an intravenous calcium channel…
The company is a specialty biopharmaceutical company that focuses on the production of therapeutics for women’s health, specifically hormonal contraceptives, utilizing the company’s own dermal drug delivery system. The company’s products …
OneMedPlace announced today that its “OneMedForum 2011” business development and finance conference for emerging healthcare and life science companies will be held January 11-13, 2011, in San Francisco at the Sir Francis Drake Hotel.
More than 50 innovative medical technology companies from around the world will present their company profiles to potential investors, partners and industry stakeholders at AdvaMed 2010: The MedTech Conference, being held October 18-20, 2010 in Washington, D.C.
Copyright © 2025 | WordPress Theme by MH Themes